Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing
Proceedings of the National Academy of Sciences · 24.11.2026 · 123 (47)
DOI: 10.1073/pnas.2625362123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.11.2026. Verfasst von Lluís Camprubí-Ferrer und 23 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, BMC B11, Lund 221 84, Sweden. Hauptthemen laut MEDLINE: Microglia, Lysosomes, Amyloid beta-Peptides, Galectin 3. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimerfonden (Alzheimer's Foundation), Olle Engkvists Stiftelse (Stiftelsen Olle Engkvist Byggmästare), Swedish Brain Power (SBP).
Abstract (Originalsprache)
Neuroinflammation is a hallmark of Alzheimer’s disease (AD), yet the molecular mechanisms linking microglial dysfunction to amyloid-β (Aβ) pathology remain incompletely understood. Here, we identify galectin-3 (Gal3) as a regulator of plaque-associated microglial responses, linking Aβ aggregation, lysosomal function, and neuritic pathology. Using postmortem brain tissue from AD patients, we found that Gal3 + microglia preferentially associate with cored plaques and correlate with increased LAMP1 + dystrophic neurites. Gal3 was also detected in microglial lysosomal compartments, extramicroglial dystrophic structures, and in association with extracellular amyloid fibrils, suggesting roles in both intracellular and extracellular Aβ processing. In APP mice, Gal3 deficiency reduced plaque burden and neuritic dystrophy, increased plaque compaction, and enhanced TREM2 coverage around amyloid plaques. Mechanistically, in vitro microglial experiments showed that Gal3 modulates Aβ uptake and lysosomal processing, whereas lysosomal dysfunction promoted the accumulation of fibrillar Aβ from initially monomeric species, particularly in Gal3-deficient cells. Cell-free assays demonstrated that Gal3 preferentially binds fibrillar Aβ, inhibits secondary nucleation, and alters fibril morphology, while Gal3-modified fibrillar Aβ reduces N2a neuronal cell number. Finally, in silico structural analyses identified candidate Gal3 interactors enriched in leucine-rich-repeat and immunoglobulin-like proteins, supporting a role for this lectin in immune receptor regulation. Complementary in vivo transcriptomic profiling showed that Gal3 deletion suppresses type I interferon and microglial neurodegenerative transcriptional signatures. Together, these findings position Gal3 at the interface between Aβ remodeling, lysosomal homeostasis, and plaque-associated microglial responses in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, BMC B11, Lund 221 84, Sweden.
- Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla 41013, Spain.
- Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla 41012, Spain.
- Biochemistry and Structural Biology, Department of Chemistry, Lund University, Lund 223 62, Sweden.
- Protein Evolution, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
- Medical Microspectroscopy, Department of Experimental Medical Science, NanoLund, MultiPark, Lund University, BMC B10, Lund 221 84, Sweden.
ORCID-Profile: Lluís Camprubí-Ferrer, Oxana Klementieva, Antonia Gutierrez, Gunnar K Gouras, Gabriel A Rabinovich
Förderung
- Alzheimerfonden (Alzheimer's Foundation)
- Olle Engkvists Stiftelse (Stiftelsen Olle Engkvist Byggmästare)
- Swedish Brain Power (SBP)
- Anna och Edwin Bergers Stiftelse (Anna and Edwin Bergers Foundation)
- Greta och Johan Kocks stiftelser (Johan and Greta Kock Trust)
- Ministerio de Ciencia, Innovación y Universidades (MCIU)
- Ministerio de Ciencia e Innovación (MCIN)
- MEC | Instituto de Salud Carlos III (ISCIII)
Zitieren
APA
Camprubí-Ferrer, L., Soldán-Hidalgo, J., Axell, E., Dell'Eva, M., García-Cruzado, M., García-Revilla, J., Yang, Y., Fernández-Calle, R., Larlham, L., Chouhan, B., Talaverón, R., Paulus, A., Danielson, L., Gomez-Arboledas, A., Klementieva, O., Gutierrez, A., Vitorica, J., Wennström, M., Gouras, G. K., …, & Deierborg, T. (2026). Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing. Proceedings of the National Academy of Sciences, 123(47). https://doi.org/10.1073/pnas.2625362123
Vancouver
Camprubí-Ferrer L, Soldán-Hidalgo J, Axell E, Dell'Eva M, García-Cruzado M, García-Revilla J, et al. Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing. Proceedings of the National Academy of Sciences. 2026;123(47). doi:10.1073/pnas.2625362123
BibTeX
@article{CamprubFerrer2026,
author = {Camprubí-Ferrer, Lluís and Soldán-Hidalgo, Jesús and Axell, Emil and Dell'Eva, Marzia and García-Cruzado, Marta and García-Revilla, Juan and Yang, Yiyi and Fernández-Calle, Rosalía and Larlham, Logan and Chouhan, Bhanu and Talaverón, Rocío and Paulus, Agnes and Danielson, Lukas and Gomez-Arboledas, Angela and Klementieva, Oxana and Gutierrez, Antonia and Vitorica, Javier and Wennström, Malin and Gouras, Gunnar K and Frontiñán-Rubio, Javier and Boza-Serrano, Antonio and Rabinovich, Gabriel A and Venero, José Luis and Deierborg, Tomas},
title = {Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {47},
doi = {10.1073/pnas.2625362123}
}
EUVIMED